相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium
Galina Lurie et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium
Linda E. Kelemen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium
Catherine M. Phelan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study
Jennifer A. Doherty et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy-A Genome-Wide Study of Japanese HCV Virus Patients
Hidenori Ochi et al.
GASTROENTEROLOGY (2010)
Evaluating the Power to Discriminate Between Highly Correlated SNPs in Genetic Association Studies
Miriam S. Udler et al.
GENETIC EPIDEMIOLOGY (2010)
The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer
K. D. Steffensen et al.
GYNECOLOGIC ONCOLOGY (2010)
The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer
Steven J. Hawken et al.
HUMAN GENETICS (2010)
Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
Pei-Chieng Cha et al.
HUMAN MOLECULAR GENETICS (2010)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Llen L. Goode et al.
NATURE GENETICS (2010)
Common variants at 19p13 are associated with susceptibility to ovarian cancer
Kelly L. Bolton et al.
NATURE GENETICS (2010)
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Antonis C. Antoniou et al.
NATURE GENETICS (2010)
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries
Ju-Hyun Park et al.
NATURE GENETICS (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer
Joellen M. Schildkraut et al.
PLOS ONE (2010)
Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer
Joellen M. Schildkraut et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
A genome-wide association study of acenocoumarol maintenance dosage
Martina Teichert et al.
HUMAN MOLECULAR GENETICS (2009)
Prognostic Importance of Vascular Endothelial Growth Factor-A Expression and Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancer
Maja Patricia Smerdel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Honglin Song et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
C. L. Pearce et al.
BRITISH JOURNAL OF CANCER (2008)
Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival
Frank Bartel et al.
CLINICAL CANCER RESEARCH (2008)
Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival
Honglin Song et al.
CLINICAL CANCER RESEARCH (2008)
The effects of common genetic variants in oncogenes on ovarian cancer survival
Lydia Quaye et al.
CLINICAL CANCER RESEARCH (2008)
Consortium analysis of 7 candidate SNPs for ovarian cancer
Susan J. Ramus et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome
Patrice Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer
Angela Chetrit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Progress and challenges in genome-wide association studies in humans
Peter Donnelly
NATURE (2008)
Genome-wide association analysis identifies 20 loci that influence adult height
Michael N. Weedon et al.
NATURE GENETICS (2008)
Polygenes, risk prediction, and targeted prevention of breast cancer
Paul D. P. Pharoah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer
Daniela B. Leite et al.
STEROIDS (2008)
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set
Jonathan Beesley et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients
J. Salvador Saldivar et al.
GYNECOLOGIC ONCOLOGY (2007)
Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes
Christina M. Nagle et al.
CANCER LETTERS (2007)
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
Simon A. Gayther et al.
CANCER RESEARCH (2007)
Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer
Lukas A. Hefler et al.
CLINICAL CANCER RESEARCH (2007)
The role of glutathione-S-transferase polymorphisms in ovarian cancer survival
Christina M. Nagle et al.
EUROPEAN JOURNAL OF CANCER (2007)
PGR +331 A/G and increased risk of epithelial ovarian cancer
Harvey A. Risch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Novel functional single nucleoticle polymorphisms in the latent transforming growth factor-β binding protein-1L promoter -: Effect on latent transforming growth factor-β binding protein-1L expression level and possible prognostic significance in ovarian cancer
Tomomi Higashi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer
Sokbom Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer
Andrea Romano et al.
GYNECOLOGIC ONCOLOGY (2006)
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer
L Six et al.
GYNECOLOGIC ONCOLOGY (2006)
TP53 and P21 polymorphisms:: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer
AM Santos et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival
A Beeghly et al.
GYNECOLOGIC ONCOLOGY (2006)
mdr-1 single nucleotide polymorphisms in ovarian cancer tissue:: G2677T/A correlates with response to paclitaxel chemotherapy
H Gréen et al.
CLINICAL CANCER RESEARCH (2006)
AIB1 polymorphisms predict aggressive ovarian cancer phenotype
AJ Li et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Polymorphisms in DNA repair genes and epithelial ovarian cancer risk
A Auranen et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Trial design for testing new therapies in ovarian cancer
EA Eisenhauer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
The influence of HER2 genotypes as molecular markers in ovarian cancer outcome
D Pinto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
YG Park et al.
NATURE GENETICS (2005)
Genetic variation in the progesterone receptor gene and ovarian cancer risk
KL Terry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Clarifying the PROGINS allele association in ovarian and breast cancer risk: A haplotype-based analysis
CL Pearce et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk
IU Agoulnik et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Association studies for finding cancer-susceptibility genetic variants
PDP Pharoah et al.
NATURE REVIEWS CANCER (2004)
Improved survival in women with BRCA-associated ovarian carcinoma
I Cass et al.
CANCER (2003)
BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk
A Auranen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Polygenic susceptibility to breast cancer and implications for prevention
PDP Pharoah et al.
NATURE GENETICS (2002)
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
AC Antoniou et al.
BRITISH JOURNAL OF CANCER (2002)
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers:: A study of hereditary nonpolyposis colorectal cancer families
HFA Vasen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer
AB Spurdle et al.
CARCINOGENESIS (2001)
p53 mutation does not affect prognosis in ovarian epithelial malignancies
S Fallows et al.
JOURNAL OF PATHOLOGY (2001)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
J Boyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
